BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mikami Y, Takeda K, Matsuda K, Qiu-Feng H, Fukuyama S, Egawa S, Sunamura M, Matsuno S. Rat experimental model of continuous regional arterial infusion of protease inhibitor and its effects on severe acute pancreatitis. Pancreas. 2005;30:248-253. [PMID: 15782103 DOI: 10.1097/01.mpa.0000153328.54569.28] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Deng ZG, Zhou JY, Yin ZY, Peng YY, Wang FQ, Wang XM. Continuous regional arterial infusion and laparotomic decompression for severe acute pancreatitis with abdominal compartment syndrome. World J Gastroenterol 2011; 17(44): 4911-4916 [PMID: 22171133 DOI: 10.3748/wjg.v17.i44.4911] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
2 Ke L, Ni HB, Tong ZH, Li WQ, Li N, Li JS. Efficacy of continuous regional arterial infusion with low-molecular-weight heparin for severe acute pancreatitis in a porcine model. Shock 2014;41:443-8. [PMID: 24430546 DOI: 10.1097/SHK.0000000000000129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
3 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2005; 13(12): 1462-1464 [DOI: 10.11569/wcjd.v13.i12.1462] [Reference Citation Analysis]
4 Piaścik M, Rydzewska G, Milewski J, Olszewski S, Furmanek M, Walecki J, Gabryelewicz A. The results of severe acute pancreatitis treatment with continuous regional arterial infusion of protease inhibitor and antibiotic: a randomized controlled study. Pancreas 2010;39:863-7. [PMID: 20431422 DOI: 10.1097/MPA.0b013e3181d37239] [Cited by in Crossref: 65] [Cited by in F6Publishing: 19] [Article Influence: 5.9] [Reference Citation Analysis]
5 Fu J, Liu Q, Liu GX, Xu XD. Diagnosis and treatment of severe acute pancreatitis: Current status and main problems. Shijie Huaren Xiaohua Zazhi 2017; 25(32): 2851-2857 [DOI: 10.11569/wcjd.v25.i32.2851] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Mansfield C, Beths T. Management of acute pancreatitis in dogs: a critical appraisal with focus on feeding and analgesia. J Small Anim Pract 2015;56:27-39. [PMID: 25586804 DOI: 10.1111/jsap.12296] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
7 Hashimoto D, Ohmuraya M, Wang J, Yamamura K, Hirota M, Baba H. Effect of Low-Molecular Weight Trypsin Inhibitor, Nafamostat Mesilate, on Trypsin Activity Using the Pancreatic Acinar Cells. Pancreas 2009;38:595-7. [DOI: 10.1097/mpa.0b013e31819156de] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Yong F, Mao X, Deng L, Zhang M, Xia Q. Continuous regional arterial infusion for the treatment of severe acute pancreatitis: a meta-analysis. Hepatobiliary & Pancreatic Diseases International 2015;14:10-7. [DOI: 10.1016/s1499-3872(14)60290-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yang F, Xie J, Wang W, Xie Y, Sun H, Jin Y, Xu D, Chen B, Andersson R, Zhou M. Regional arterial infusion with lipoxin A4 attenuates experimental severe acute pancreatitis. PLoS One. 2014;9:e108525. [PMID: 25265022 DOI: 10.1371/journal.pone.0108525] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
10 Endo A, Shiraishi A, Fushimi K, Murata K, Otomo Y. Impact of continuous regional arterial infusion in the treatment of acute necrotizing pancreatitis: analysis of a national administrative database. J Gastroenterol 2018;53:1098-106. [PMID: 29564566 DOI: 10.1007/s00535-018-1452-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
11 Maeda K, Hirota M, Ichihara A, Ohmuraya M, Hashimoto D, Sugita H, Takamori H, Kanemitsu K, Baba H. Applicability of disseminated intravascular coagulation parameters in the assessment of the severity of acute pancreatitis. Pancreas. 2006;32:87-92. [PMID: 16340749 DOI: 10.1097/01.mpa.0000186248.89081.44] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
12 Fukushima H, Fukushima T, Suzuki R, Enokizono T, Matsunaga M, Nakao T, Koike K, Mori K, Matsueda K, Sumazaki R. Continuous regional arterial infusion effective for children with acute necrotizing pancreatitis even under neutropenia. Pediatr Int. 2013;55:e11-e13. [PMID: 23679174 DOI: 10.1111/j.1442-200x.2012.03702.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
13 Wada K, Takada T, Hirata K, Mayumi T, Yoshida M, Yokoe M, Kiriyama S, Hirota M, Kimura Y, Takeda K. Treatment strategy for acute pancreatitis. J Hepatobiliary Pancreat Sci. 2010;17:79-86. [PMID: 20012325 DOI: 10.1007/s00534-009-0218-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
14 Zhou M, Chen B, Sun H, Chen X, Yu Z, Shi H, Yao J, Xu Z, Zhang Q, Andersson R. The efficiency of continuous regional intra-arterial infusion in the treatment of infected pancreatic necrosis. Pancreatology 2013;13:212-5. [DOI: 10.1016/j.pan.2013.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
15 Uwagawa T, Sakamoto T, Yasuda J, Shiozaki H, Furukawa K, Onda S, Gocho T, Shiba H, Yanaga K. Phase II Study of Adjuvant Chemotherapy With Gemcitabine and Nafamostat Mesilate for Pancreatic Cancer. Pancreas 2021;50:313-6. [PMID: 33835961 DOI: 10.1097/MPA.0000000000001767] [Reference Citation Analysis]
16 Hamada T, Yasunaga H, Nakai Y, Isayama H, Horiguchi H, Matsuda S, Fushimi K, Koike K. Continuous regional arterial infusion for acute pancreatitis: a propensity score analysis using a nationwide administrative database. Crit Care 2013;17:R214. [PMID: 24088324 DOI: 10.1186/cc13029] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
17 Zhou MT, Chen BC, Sun HW, Jin YP, Yang FJ, Zhang X, Andersson R, Zhang QY. Continuous regional arterial infusion with fluorouracil and octreotide attenuates severe acute pancreatitis in a canine model. PLoS One. 2012;7:e37347. [PMID: 22655040 DOI: 10.1371/journal.pone.0037347] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
18 Mine T, Morizane T, Kawaguchi Y, Akashi R, Hanada K, Ito T, Kanno A, Kida M, Miyagawa H, Yamaguchi T, Mayumi T, Takeyama Y, Shimosegawa T. Clinical practice guideline for post-ERCP pancreatitis. J Gastroenterol. 2017;52:1013-1022. [PMID: 28653082 DOI: 10.1007/s00535-017-1359-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 7.6] [Reference Citation Analysis]
19 Lee JK, Ryu JK, Park JK, Lee SH, Yoon WJ, Kim Y, Jung HC, Yoon YB. Effects of Nafamostat Mesilate on the Prevention of Cerulein-Induced Acute Pancreatitis. Pancreas 2008;36:255-60. [DOI: 10.1097/mpa.0b013e31815b6b10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
20 Uwagawa T, Misawa T, Tsutsui N, Ito R, Gocho T, Hirohara S, Sadaoka S, Yanaga K. Phase II study of gemcitabine in combination with regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer. Am J Clin Oncol. 2013;36:44-48. [PMID: 22157216 DOI: 10.1097/coc.0b013e31823a53b2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
21 Hirota M, Shimosegawa T, Kitamura K, Takeda K, Takeyama Y, Mayumi T, Ito T, Takenaka M, Iwasaki E, Sawano H, Ishida E, Miura S, Masamune A, Nakai Y, Mitoro A, Maguchi H, Kimura K, Sanuki T, Ito T, Haradome H, Kozaka K, Gabata T, Kataoka K, Hirota M, Isaji S, Nakamura R, Yamagiwa K, Kayaba C, Ikeda K. Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial. J Gastroenterol 2020;55:342-52. [PMID: 31758329 DOI: 10.1007/s00535-019-01644-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
22 Uwagawa T, Misawa T, Sakamoto T, Ito R, Gocho T, Shiba H, Wakiyama S, Hirohara S, Sadaoka S, Yanaga K. A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer. Ann Oncol. 2009;20:239-243. [PMID: 18836085 DOI: 10.1093/annonc/mdn640] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]